Detalles de la búsqueda
1.
The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis.
Leuk Lymphoma
; 55(6): 1266-73, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23987821
2.
Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysis.
Clinicoecon Outcomes Res
; 6: 141-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24729719
3.
Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study.
Ther Adv Hematol
; 4(3): 157-71, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23730494
Resultados
1 -
3
de 3
1
Próxima >
>>